Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB)

Alyautdin R, 1995, Eur J Pharm Biopharm, 41, 44

Alyautdin RN, 1997, Pharm Res, 14, 325, 10.1023/A:1012098005098

10.3109/10611860108997929

Alyautdin RN, 1998, J Microencapsul, 5, 67, 10.3109/02652049809006836

Ambruosi A, 2006, J Microencapsul, 23, 582, 10.1080/02652040600788080

Begley DJ, 1996, J Pharm Pharmacol, 48, 136, 10.1111/j.2042-7158.1996.tb07112.x

Begley DJ, 2004, Pharmacol Therap, 104, 29, 10.1016/j.pharmthera.2004.08.001

10.1016/0378-5173(94)90372-7

Brightman M, 1992, Handbook of experimental pharmacology. physiology and pharmacology of the blood-brain barrier, 103, 1, 10.1007/978-3-642-76894-1_1

Cordon-Cardo C, 1989, Proc Natl Acad Sci USA, 86, 695, 10.1073/pnas.86.2.695

Friese A, 2000, Eur J Pharm Biopharm, 49, 103, 10.1016/S0939-6411(99)00073-9

10.1016/S0378-4274(01)00456-8

Gelperina S, 2010, Eur J Pharm Biopharm, 74, 157, 10.1016/j.ejpb.2009.09.003

Gulyaev AE, 1999, Pharm Res, 16, 1564, 10.1023/A:1018983904537

10.1074/jbc.M805956200

10.5414/NPP28153

Kreuter J, 2001, Adv Drug Deliv Rev, 47, 65, 10.1016/S0169-409X(00)00122-8

Kreuter J, 2006, Nanoparticles as drug carriers, 527, 10.1142/9781860949074_0024

Kreuter J, 1995, Brain Res, 674, 171, 10.1016/0006-8993(95)00023-J

Kreuter J, 2007, J Controlled Rel, 118, 54, 10.1016/j.jconrel.2006.12.012

Kreuter J, 1997, J Controlled Rel, 49, 81, 10.1016/S0168-3659(97)00061-8

Kreuter J, 2003, Pharm Res, 20, 409, 10.1023/A:1022604120952

10.1080/10611860290031877

10.1080/10611860903112842

Lück M, 1997. Plasmaproteinadsorption als möglicher Schlüsselfaktor für eine kontrollierte Arzneistoffapplikation mit partikulären Trägern. PhD Thesis, Berlin, Freie Universität, pp. 14–24, 137–54

10.1124/jpet.105.097139

Nerurkar MM, 1996, Pharm Res, 13, 528, 10.1023/A:1016033702220

Neuwelt EA, 1989, Implications of the blood-brain barrier and its manipulation, 2, 195, 10.1007/978-1-4615-7255-8_5

10.1023/A:1018947208597

Pereverzeva E, 2008, Toxicol Letters, 178, 9, 10.1016/j.toxlet.2008.01.020

10.1016/j.ijpharm.2007.01.031

Petri B, 2007, J Controlled Rel, 117, 51, 10.1016/j.jconrel.2006.10.015

Ramge P, 2000, Europ J Neurosci, 12, 1931, 10.1046/j.1460-9568.2000.00078.x

Sanchez de Juan B, 2006, J Drug Target, 14, 614, 10.1080/10611860600866872

Steiniger SCJ, 2004, Int J Cancer, 109, 759, 10.1002/ijc.20048

Tahara K, 2011, J Microencapsul, 28, 29, 10.3109/02652048.2010.522258

Ulbrich K, 2009, Eur J Pharm Biopharm, 71, 251, 10.1016/j.ejpb.2008.08.021

10.3109/10611861003734001

10.1371/journal.pone.0014213

Wohlfart S, 2009, J Nanoneurosci, 1, 144, 10.1166/jns.2009.1003

Wohlfart S, Gelperina S, Kreuter J, Transport of drugs across the blood-brain barrier by nanoparticles. J Controlled Rel (e-publ. 2011)

10.1016/j.ijpharm.2011.05.046

Wohlfart S, 2011, J Controlled Rel, 154, 103, 10.1016/j.jconrel.2011.05.010

Wohlfart S, 2011, PLoS ONE, 6, e19121, 10.1371/journal.pone.0019121

10.1038/bjc.1992.217

10.3109/1061186X.2010.513712

Zensi A, 2009, J Controlled Rel, 137, 78, 10.1016/j.jconrel.2009.03.002